What researchers study
TB-500 is marketed as a thymosin-β4-related research peptide and is investigated primarily around cell migration, angiogenesis, connective tissue and wound-repair biology.
Research-use context: “What it is used for” below means what scientists and clinical researchers have investigated—not an instruction or recommendation for personal use.
Potential side effects & unknowns
Human safety data for TB-500 itself are sparse. Human wound-healing studies of thymosin-β4 are not interchangeable with injected TB-500. For musculoskeletal use, recent reviews conclude that human evidence is lacking and safety, dosing and duration remain uncertain.
Research highlight
Thymosin-β4 research has shown faster repair in several wound models and some human topical wound studies. For TB-500 specifically, the evidence is predominantly preclinical, so claims of faster sports-injury recovery in people are not established.
Related video
Dr. Jones, DC: Doctor Explains How the FDA Vote Changes BPC-157, TB-500, KPV & MOTS-c
Additional commentary from Dr. Dean Jones, DC. This video is embedded for context and education; WILGO does not control or independently verify claims made in third-party videos.
Independent third-party content: Dr. Dean Jones, DC, is not affiliated with WILGO or WILGO's suppliers. Embedding his publicly available video does not imply sponsorship, endorsement, partnership, or approval by Dr. Jones, WILGO, or any supplier.
Video hosted by YouTube. Opening or playing it may be subject to YouTube's privacy terms.
Looking for TB-500?
Follow the tracked WILGO product link to see current inventory, exact product specifications and checkout pricing.